Efficacy of vedolizumab in granulomatous cheilitis refractory to TNFα inhibitors

Int J Dermatol. 2019 Dec;58(12):e236-e237. doi: 10.1111/ijd.14638. Epub 2019 Sep 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / pharmacology
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Azathioprine / pharmacology
  • Azathioprine / therapeutic use
  • Crohn Disease / complications
  • Crohn Disease / drug therapy*
  • Crohn Disease / immunology
  • Drug Resistance
  • Female
  • Humans
  • Infliximab / pharmacology
  • Infliximab / therapeutic use
  • Melkersson-Rosenthal Syndrome / drug therapy*
  • Melkersson-Rosenthal Syndrome / immunology
  • Recurrence
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / immunology
  • Young Adult

Substances

  • Antibodies, Monoclonal, Humanized
  • TNF protein, human
  • Tumor Necrosis Factor-alpha
  • vedolizumab
  • Infliximab
  • Azathioprine